VSTM Verastem Inc

Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib (VS-6063).

$4.43  +0.17 (3.87%)
As of 06/24/2021 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/27/2012
Outstanding shares:  171,919,345
Average volume:  3,304,404
Market cap:   $735,814,797
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    92337C104
ISIN:        US92337C1045
Sedol:      B4Z1Y92
Valuation   (See tab for details)
PE ratio:   -16.36
PB ratio:   7.14
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy